Navigation Links
Discovery clarifies role of peptide in biological clock

A biologist at Washington University in St. Louis is giving the VIP treatment to laboratory mice in hopes of unraveling more clues about our biological clock.

VIP is not "very important person," but vasoactive intestinal polypeptide (VIP), a neuropeptide originally found in the gut, that is also made by a specialized group of neurons in the brain.

Erik Herzog, Ph.D., Washington University assistant professor of Biology in Arts & Sciences, has discovered that VIP is needed by the brain's biological clock to coordinate daily rhythms in behavior and physiology. Neurons in the biological clock, an area called the suprachiasmatic nucleus (SCN), keep 24-hour time and are normally synchronized as a well-oiled marching band coming onto the field at half time. Herzog and graduate student, Sara Aton, found that mice lacking the gene that makes VIP or lacking the receptor molecule for VIP suffer from internal de-synchrony. When they recorded the electrical activity of SCN neurons from these mice, they found that many had lost their beat while others were cycling but unable to synch to each other.

But when Herzog and Aton added VIP to the mice cells, the synchronicity was restored, showing that VIP couples pacemaker cells and drives rhythms in slave cells.

"VIP between SCN neurons is like a rubber band between the pendulums of two grandfather clocks, helping to synchronize their timing. Some researchers had proposed that knocking out VIP or the receptor for it stopped the clock," Herzog said. "We've found that the biological clock is still running, but its internal synchrony is uncoordinated. This causes irregular patterns of sleep and wake, for example."

The study was published on-line in Nature Neuroscience on March 6, 2005. Herzog's work is funded by the National Institutes of Health.

"In a light-dark schedule, these mice looked normal, but as soon as you leave off the lights, they reveal their internal de-synchrony," he sai d. "The mice showed multiple rhythms, getting up both earlier and earlier and later and later on subsequent days so that their daily activity patterns were splitting apart."

Herzog and Aton recorded neuron activity from the SCN using a multielectrode array with 60 electrodes upon which they place SCN cells, a "clock in a dish." This enabled them to record data from many cells for many days.

"We found that the VIP mutants, indeed, can generate circadian rhythms, but the neurons can't synchronize to each other," Herzog said. "We showed that we could restore rhythms to the arrhythmic neurons and synchrony to the SCN by providing VIP once a day."

The SCN is a part of the hypothalamus that can be found on the bottom of the brain just above the roof of your mouth where your optic nerves cross. There are roughly 10,000 neurons in this nucleus on either side of your brain. The timekeeping mechanism in these cells depends on daily cycles in gene activity.

Herzog found in his latest study that the percentage of rhythmic cells in the mutant SCN was very low, and he believes these rhythmic neurons are specialized circadian pacemakers.

"We suspect that at least some of the pace making cells in the SCN are VIP cells, and one of the things we'll try to do next is confirm this. We will also try to understand better how VIP synchronizes pacemakers," he said.

It is surprising that the process is regulated by a peptide, usually a slow signaling agent, rather than a neurotransmitter, associated with fast events, Herzog said.

"We're trying to understand the mechanics of how the system synchronizes and the secondary messenger systems as well," Herzog said. "We're getting closer to the heart and soul of circadian rhythmicity by uncoupling the (biological) clock."


'"/>

Source:Washington University in St. Louis


Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Could Lead To Novel Approaches In HIV Treatment
5. Discovery Promises Simpler Therapy for Sickle Cell Disease
6. Discovery may lead to better Candidiasis drug
7. Protein Discovery Could Unlock The Secret To Better TB Treatment
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/17/2016)... 17, 2016  AIC announces that it has just released a new white paper ... high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or HPC ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... Research and Markets has announced the addition of Jain PharmaBiotech,s ... their offering. ... This report describes different types ... proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery ... Currently the most important applications of biomarkers are in drug ...
(Date:12/5/2016)... ... December 05, 2016 , ... In anticipation ... and lumbar disc production, company President, Jake Lubinski will be traveling to Germany ... AxioMed disc in Cologne and Karlsruhe to discuss the benefits of a viscoelastic ...
(Date:12/5/2016)...  Renova™ Therapeutics, a biotechnology company developing gene ... chronic diseases, announced that Catherine Bovenizer , ... Officer (CFO), effective today. Ms. Bovenizer ... in financial management for a variety of public ... recently, Ms. Bovenizer was the Vice President of ...
(Date:12/5/2016)... 5, 2016 NxGen MDx announced today that it brought its ... house, we,ve been able to improve customer service through shortened turnaround times ... Alan Mack , CEO of NxGen MDx. ... , A decrease in turnaround ... to more job opportunities at the Grand Rapid headquarters. The ...
Breaking Biology Technology: